BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strope JD, PharmD CHC, Figg WD. TMPRSS2: Potential Biomarker for COVID-19 Outcomes. J Clin Pharmacol 2020;60:801-7. [PMID: 32437018 DOI: 10.1002/jcph.1641] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Kishk SM, Kishk RM, Yassen ASA, Nafie MS, Nemr NA, ElMasry G, Al-Rejaie S, Simons C. Molecular Insights into Human Transmembrane Protease Serine-2 (TMPS2) Inhibitors against SARS-CoV2: Homology Modelling, Molecular Dynamics, and Docking Studies. Molecules 2020;25:E5007. [PMID: 33137894 DOI: 10.3390/molecules25215007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Shrimp JH, Kales SC, Sanderson PE, Simeonov A, Shen M, Hall MD. An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19. ACS Pharmacol Transl Sci 2020;3:997-1007. [PMID: 33062952 DOI: 10.1021/acsptsci.0c00106] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 16.0] [Reference Citation Analysis]
3 El Amri C. Serine Protease Inhibitors to Treat Lung Inflammatory Diseases. Adv Exp Med Biol 2021;1304:215-26. [PMID: 34019272 DOI: 10.1007/978-3-030-68748-9_13] [Reference Citation Analysis]
4 Strope JD, Chau CH, Figg WD. Are sex discordant outcomes in COVID-19 related to sex hormones? Semin Oncol 2020;47:335-40. [PMID: 32660890 DOI: 10.1053/j.seminoncol.2020.06.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
5 Thunders M, Delahunt B. Gene of the month: TMPRSS2 (transmembrane serine protease 2). J Clin Pathol 2020;73:773-6. [PMID: 32873700 DOI: 10.1136/jclinpath-2020-206987] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
6 Kaur T, Kapila S, Kapila R, Kumar S, Upadhyay D, Kaur M, Sharma C. Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint. Virus Res 2021;294:198275. [PMID: 33359190 DOI: 10.1016/j.virusres.2020.198275] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
7 Jahanafrooz Z, Chen Z, Bao J, Li H, Lipworth L, Guo X. An overview of human proteins and genes involved in SARS-CoV-2 infection. Gene 2022;808:145963. [PMID: 34530086 DOI: 10.1016/j.gene.2021.145963] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
8 Sarkar N, Thakur A, Ghadge J, Rath SL. Computational studies reveal Fluorine based quinolines to be potent inhibitors for proteins involved in SARS-CoV-2 assembly. J Fluor Chem 2021;250:109865. [PMID: 34393265 DOI: 10.1016/j.jfluchem.2021.109865] [Reference Citation Analysis]
9 Lipsa A, Prabhu JS. Gender disparity in COVID-19: Role of sex steroid hormones. Asian Pac J Trop Med 2021;14:5-9. [PMID: 33828641 DOI: 10.4103/1995-7645.304293] [Reference Citation Analysis]
10 Abolfazli P, Aghajanzadeh T, Ghaderinasrabad M, Apue Nchama CN, Mokhlesi A, Talkhabi M. Bioinformatics analysis reveals molecular connections between non-alcoholic fatty liver disease (NAFLD) and COVID-19. J Cell Commun Signal 2022. [PMID: 35525888 DOI: 10.1007/s12079-022-00678-y] [Reference Citation Analysis]
11 Wu CY, Lin YS, Yang YH, Shu LH, Cheng YC, Liu HT. GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies. Biomed Pharmacother 2020;132:110816. [PMID: 33049583 DOI: 10.1016/j.biopha.2020.110816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Kim HA, Kim JE. Development of Nafamostat Mesylate Immediate-Release Tablet by Drug Repositioning Using Quality-by-Design Approach. Pharmaceutics 2022;14:1219. [PMID: 35745792 DOI: 10.3390/pharmaceutics14061219] [Reference Citation Analysis]
13 Muralidar S, Gopal G, Visaga Ambi S. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19. J Med Virol 2021;93:5260-76. [PMID: 33851732 DOI: 10.1002/jmv.27019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Gioia M, Ciaccio C, Calligari P, De Simone G, Sbardella D, Tundo G, Fasciglione GF, Di Masi A, Di Pierro D, Bocedi A, Ascenzi P, Coletta M. Role of proteolytic enzymes in the COVID-19 infection and promising therapeutic approaches. Biochem Pharmacol 2020;182:114225. [PMID: 32956643 DOI: 10.1016/j.bcp.2020.114225] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
15 Zhang F, Waters M. Pathogen Genomics and Host Cellular Susceptibility Factors of COVID-19. Glob Clin Transl Res. [DOI: 10.36316/gcatr.02.0037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Tarek M, Abdelzaher H, Kobeissy F, El-Fawal HAN, Salama MM, Abdelnaser A. Bioinformatics Analysis of Allele Frequencies and Expression Patterns of ACE2, TMPRSS2 and FURIN in Different Populations and Susceptibility to SARS-CoV-2. Genes (Basel) 2021;12:1041. [PMID: 34356057 DOI: 10.3390/genes12071041] [Reference Citation Analysis]
17 Abdelsattar S, Kasemy ZA, Ewida SF, Abo-elsoud RAA, Zytoon AA, Abdelaal GA, Abdelgawad AS, Khalil FO, Kamel HFM. ACE2 and TMPRSS2 SNPs as Determinants of Susceptibility to, and Severity of, a COVID-19 Infection. Br J Biomed Sci 2022;79:10238. [DOI: 10.3389/bjbs.2021.10238] [Reference Citation Analysis]
18 Chang R, Mamun A, Dominic A, Le NT. SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress. Front Physiol 2020;11:605908. [PMID: 33519510 DOI: 10.3389/fphys.2020.605908] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
19 Luo L, Zheng Y, Li M, Lin X, Li X, Li X, Cui L, Luo H. TMPRSS2 Correlated With Immune Infiltration Serves as a Prognostic Biomarker in Prostatic Adenocarcinoma: Implication for the COVID-2019. Front Genet 2020;11:575770. [PMID: 33193689 DOI: 10.3389/fgene.2020.575770] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Umesh A, Pranay K, Pandey RC, Gupta MK. Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. Infection 2022. [PMID: 35489015 DOI: 10.1007/s15010-022-01835-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Niedźwiedzka-Rystwej P, Majchrzak A, Kurkowska S, Małkowska P, Sierawska O, Hrynkiewicz R, Parczewski M. Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm. Int J Mol Sci 2022;23:4545. [PMID: 35562935 DOI: 10.3390/ijms23094545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Lisi L, Lacal PM, Barbaccia ML, Graziani G. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2. Biochem Pharmacol 2020;180:114169. [PMID: 32710969 DOI: 10.1016/j.bcp.2020.114169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
23 Sunkara H, Dewan SMR. Coronavirus disease-2019: A review on the disease exacerbation via cytokine storm and concurrent management. Int Immunopharmacol 2021;99:108049. [PMID: 34426104 DOI: 10.1016/j.intimp.2021.108049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Ibrahim S, Monaco GSF, Sims EK. Not so sweet and simple: impacts of SARS-CoV-2 on the β cell. Islets 2021;13:66-79. [PMID: 33970787 DOI: 10.1080/19382014.2021.1909970] [Reference Citation Analysis]
25 Prasanna PG, Woloschak GE, DiCarlo AL, Buchsbaum JC, Schaue D, Chakravarti A, Cucinotta FA, Formenti SC, Guha C, Hu DJ, Khan MK, Kirsch DG, Krishnan S, Leitner WW, Marples B, McBride W, Mehta MP, Rafii S, Sharon E, Sullivan JM, Weichselbaum RR, Ahmed MM, Vikram B, Coleman CN, Held KD. Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks? Radiat Res 2020;194:452-64. [PMID: 33045077 DOI: 10.1667/RADE-20-00211.1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 6.5] [Reference Citation Analysis]
26 Calderón-Garcidueñas L, Torres-Jardón R, Franco-Lira M, Kulesza R, González-Maciel A, Reynoso-Robles R, Brito-Aguilar R, García-Arreola B, Revueltas-Ficachi P, Barrera-Velázquez JA, García-Alonso G, García-Rojas E, Mukherjee PS, Delgado-Chávez R. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution. J Alzheimers Dis 2020;78:479-503. [PMID: 32955466 DOI: 10.3233/JAD-200891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
27 Villapalos-García G, Zubiaur P, Rivas-Durán R, Campos-Norte P, Arévalo-Román C, Fernández-Rico M, García-Fraile Fraile L, Fernández-Campos P, Soria-Chacartegui P, Fernández de Córdoba-Oñate S, Delgado-Wicke P, Fernández-Ruiz E, González-Álvaro I, Sanz J, Abad-Santos F, de Los Santos I. Transmembrane protease serine 2 (TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity. Life Sci Alliance 2022;5:e202201396. [PMID: 35636966 DOI: 10.26508/lsa.202201396] [Reference Citation Analysis]
28 Syed F, Li W, Relich RF, Russell PM, Zhang S, Zimmerman MK, Yu Q. Excessive matrix metalloproteinase-1 and hyperactivation of endothelial cells occurred in COVID-19 patients and were associated with the severity of COVID-19. medRxiv 2021:2021. [PMID: 33501465 DOI: 10.1101/2021.01.19.21250115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Rani P, Kapoor B, Gulati M, Atanasov AG, Alzahrani Q, Gupta R. Antimicrobial peptides: A plausible approach for COVID-19 treatment. Expert Opin Drug Discov 2022;:1-15. [PMID: 35255763 DOI: 10.1080/17460441.2022.2050693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Williams FMK, Freidin MB, Mangino M, Couvreur S, Visconti A, Bowyer RCE, Le Roy CI, Falchi M, Mompeó O, Sudre C, Davies R, Hammond C, Menni C, Steves CJ, Spector TD. Self-Reported Symptoms of COVID-19, Including Symptoms Most Predictive of SARS-CoV-2 Infection, Are Heritable. Twin Res Hum Genet 2020;23:316-21. [PMID: 33558003 DOI: 10.1017/thg.2020.85] [Cited by in Crossref: 7] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
31 Yildirim Z, Sahin OS, Yazar S, Bozok Cetintas V. Genetic and epigenetic factors associated with increased severity of Covid-19. Cell Biol Int 2021;45:1158-74. [PMID: 33590936 DOI: 10.1002/cbin.11572] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
32 Shrimp JH, Kales SC, Sanderson PE, Simeonov A, Shen M, Hall MD. An Enzymatic TMPRSS2 Assay for Assessment of Clinical Candidates and Discovery of Inhibitors as Potential Treatment of COVID-19. bioRxiv 2020:2020. [PMID: 32596694 DOI: 10.1101/2020.06.23.167544] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 6.5] [Reference Citation Analysis]